Every year 41,000 men are diagnosed with prostate cancer in the UK. Dr Hayley Whitaker is a Cancer Research UK scientist who specialises in prostate cancer. We hear about her quest for better screening for the disease. Dr Whitaker is lead author of a study about how a particular protein helps identify if a prostate cancer patient needs more intense treatment. The protein is called NAALADL2 and is linked to the spread of prostate cancer tumour cells to surrounding healthy tissues. Dr Whitaker hopes that a test for the protein may spare patients unnecessary treatment.

Learn more about research at the Cancer Research UK Cambridge Institute (CRUK)

Read Dr Whitaker’s research article in Oncogene

11/01/2014 Tagged 105science, biology, cancer, cancer research, Chris Creese, CRUK, Hayley Whitaker, health, prostate, Roger Frost, tumour